Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
Bio-Rad Laboratories (NYSE: BIO and BIO.B) has announced its participation in Citi's 2024 Global Healthcare Conference in Miami, FL, scheduled for December 3-5, 2024. The company's CEO Norman Schwartz and CFO Roop K. Lakkaraju will conduct one-on-one meetings with analysts and investors during the event. Bio-Rad, recognized as a global leader in life science research and clinical diagnostics products, aims to engage directly with the investment community through these meetings.
Bio-Rad Laboratories (NYSE: BIO e BIO.B) ha annunciato la sua partecipazione alla Global Healthcare Conference 2024 di Citi che si svolgerà a Miami, FL, dal 3 al 5 dicembre 2024. L'amministratore delegato della società, Norman Schwartz, e il direttore finanziario, Roop K. Lakkaraju, condurranno incontri individuali con analisti e investitori durante l'evento. Bio-Rad, riconosciuta come leader globale nella ricerca nelle scienze della vita e nei prodotti di diagnostica clinica, mira a interagire direttamente con la comunità degli investitori attraverso questi incontri.
Bio-Rad Laboratories (NYSE: BIO y BIO.B) ha anunciado su participación en la Conferencia Global de Salud 2024 de Citi que se llevará a cabo en Miami, FL, del 3 al 5 de diciembre de 2024. El CEO de la empresa, Norman Schwartz, y el CFO, Roop K. Lakkaraju, llevarán a cabo reuniones individuales con analistas e inversores durante el evento. Bio-Rad, reconocido como líder global en investigación en ciencias de la vida y productos de diagnóstico clínico, tiene como objetivo interactuar directamente con la comunidad de inversores a través de estas reuniones.
바이오래드 연구소 (NYSE: BIO 및 BIO.B)는 2024년 12월 3일부터 5일까지 플로리다주 마이애미에서 열리는 Citi의 2024 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 CEO인 노먼 슈워츠와 CFO인 루프 K. 라카라주가 이 행사 동안 애널리스트 및 투자자와 개별 미팅을 진행할 예정입니다. 바이오래드는 생명 과학 연구 및 임상 진단 제품의 글로벌 리더로 인정받고 있으며, 이러한 미팅을 통해 투자자 커뮤니티와 직접 소통할 계획입니다.
Bio-Rad Laboratories (NYSE: BIO et BIO.B) a annoncé sa participation à la Conférence mondiale sur la santé 2024 de Citi, qui se tiendra à Miami, FL, du 3 au 5 décembre 2024. Le PDG de l'entreprise, Norman Schwartz, et le CFO, Roop K. Lakkaraju, procéderont à des réunions individuelles avec des analystes et des investisseurs durant cet événement. Bio-Rad, reconnu comme un leader mondial dans la recherche en sciences de la vie et les produits de diagnostic clinique, vise à interagir directement avec la communauté des investisseurs à travers ces réunions.
Bio-Rad Laboratories (NYSE: BIO und BIO.B) hat seine Teilnahme an der Citi's 2024 Global Healthcare Conference in Miami, FL, die vom 3. bis 5. Dezember 2024 stattfindet, angekündigt. Der CEO des Unternehmens, Norman Schwartz, und der CFO, Roop K. Lakkaraju, werden während der Veranstaltung Einzelgespräche mit Analysten und Investoren führen. Bio-Rad, das als globaler Marktführer in der Lebenswissenschaftsforschung und klinischen Diagnostik anerkannt ist, beabsichtigt, über diese Gespräche direkt mit der Investmentgemeinschaft in Kontakt zu treten.
- None.
- None.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241121721098/en/
Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com
Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com
Source: Bio-Rad Laboratories, Inc.
FAQ
When is Bio-Rad (BIO) participating in Citi's 2024 Global Healthcare Conference?
Who will represent Bio-Rad (BIO) at Citi's 2024 Healthcare Conference?
What type of meetings will Bio-Rad (BIO) hold at the Citi Healthcare Conference 2024?
Where will Citi's 2024 Global Healthcare Conference featuring Bio-Rad (BIO) take place?
